WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention : use of mRNA tests for human papillomavirus (HPV).Second edition

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention use of mRNA tests for human papillomavirus (HPV).Second edition

Detalles Bibliográficos
Autor principal: World Health Organization (author)
Autor Corporativo: World Health Organization, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Geneva, Switzerland : World Health Organization 2021.
Edición:2nd ed
Materias:
Medical screening.
Cervix uteri > Cancer.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009648335906719
Tabla de Contenidos:
  • Intro
  • Contents
  • Acronyms and abbreviations
  • Acknowledgements
  • Executive summary
  • Background
  • Methods
  • 1. Introduction
  • 1.1 Background
  • 1.2 Approaches to screening and treatment
  • 1.3 Rationale for this new edition of recommendations
  • 1.4 Phased approach for the development of the recommendations
  • 1.5 Target audience
  • 2. Methods
  • 2.1 Groups contributing to the guideline development process
  • Declarations and management of conflicts of interest
  • Confidentiality
  • 2.2 Scoping review and appraisal of the existing recommendations
  • 2.3 Priority questions for review of evidence
  • 2.4 Priority algorithms
  • 2.5 Outcomes
  • 2.6 Syntheses of evidence
  • 2.6.1 Methods used for systematic literature reviews
  • 3. Important considerations for the recommendations
  • 3.1 Programme considerations
  • 3.2 Screening and triage tests considered in these guidelines
  • References
  • Annexes
  • Annex 1: Guideline groups
  • Annex 2. Evidence-gathering teams and guideline task groups
  • Annex 3. Declarations of interests
  • Annex 4. Seven algorithms prioritized for Phase 1 of the guideline update
  • Annex 5. Standardized definitions used in this guideline
  • Acknowledgements
  • Acronyms and abbreviations
  • Executive summary
  • Background
  • Methods
  • Summary of recommendations for the use of HPV mRNA testing to prevent cervical cancer
  • 1. Introduction
  • 1.1 Background
  • 1.2 HPV mRNA technology and interpretation of test results
  • 1.3 Phased approach for development of updated recommendations and purpose of this guideline
  • 1.5 Previous and existing WHO recommendations for screening and treatment to prevent cervical cancer and definitions
  • 1.7 Target audience
  • 2. Methods for development of recommendations on HPV mRNA testing
  • 2.1. Groups contributing to the guideline development process.
  • 2.2 Scoping review and appraisal of the existing recommendations
  • 2.3 Priority algorithms
  • 2.4 Outcomes
  • 2.5 Syntheses of evidence
  • 2.6 Development of the recommendations
  • 2.7 Management of the external peer review
  • 3. Recommendations on HPV mRNA testing
  • 4. Research gaps and further considerations for HPV mRNA testing
  • 5. Dissemination and updating of the guideline
  • 5.1 Guideline dissemination and impact
  • 5.2 Guideline update
  • References
  • Annexes
  • Annex 1. Guideline groups
  • Annex 2. Evidence-gathering teams and guideline task groups
  • Annex 3. Declarations of interests
  • Annex 4. Algorithms for use of HPV mRNA tests in the general population of women
  • Annex 5. Recommendations from Phase 1 of the guideline update: HPV DNA tests and other cervical screening methods1.

Ejemplares similares